2.310USD-1.70%Mkt Cap: 36.79M USDP/E: —Last update: 2026-05-26
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and inter…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap36.79M USD
Enterprise Value23.24M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-22.73M USD
Revenue/Share—
Last Price2.310 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees20
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92536C1036
Valuation
P/E (Trailing)—
P/E (Forward)-2.25
PEG3.60
EV/EBITDA-0.83
EV/Revenue—
P/S—
P/B0.96
EPS (TTM)-0.80
EPS (Forward)-0.98
52W Range
2.0505% of range7.400
52W High7.400 USD
52W Low2.050 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-123.97%
ROA-76.17%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-30.04M USD
CapEx (TTM)1.08K USD
FCF Margin—
FCF Yield-28.28%
Net Debt-27.93M USD
Net Debt/EBITDA1.00
Balance Sheet
Debt/Equity0.17
Current Ratio6.19
Quick Ratio5.71
Book Value/Sh2.313 USD
Cash/Share1.335 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield3.71%
Payout Ratio0.00%
Ex-Div DateApr 28, 2014
Pay DateMay 7, 2014
Splits
Last Split1:10
Split DateAug 11, 2025
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)24.50 USD
Target Range24.00 USD – 25.00 USD
# Analysts2
Ownership
Shares Out.16.05M
Float19.36M
Insiders9.78%
Institutions23.88%
Short Interest
Short Ratio10.9d
Short % Float3.99%
Short % Out.3.60%
Shares Short577.16K
Short (prev mo.)670.73K
Technical
SMA 502.300 (+0.5%)
SMA 2002.793 (-17.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)57.22K
Avg Vol (10d)61.14K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—